Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zic3
|
ENSMUSG00000067860.5 | zinc finger protein of the cerebellum 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_58038370_58038794 | Zic3 | 7572 | 0.264616 | -0.79 | 4.7e-13 | Click! |
chrX_58038827_58039019 | Zic3 | 7913 | 0.263229 | -0.78 | 3.2e-12 | Click! |
chrX_58038126_58038313 | Zic3 | 7209 | 0.266258 | -0.75 | 3.6e-11 | Click! |
chrX_58030199_58030644 | Zic3 | 222 | 0.954590 | -0.69 | 4.1e-09 | Click! |
chrX_58030692_58030893 | Zic3 | 149 | 0.971100 | -0.68 | 8.7e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_152549002_152549525 | 87.09 |
Ak5 |
adenylate kinase 5 |
22511 |
0.2 |
chr18_36274707_36275097 | 31.93 |
Pura |
purine rich element binding protein A |
6195 |
0.2 |
chr2_171863445_171863658 | 27.02 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
98580 |
0.07 |
chr2_171864030_171864181 | 23.40 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
98026 |
0.07 |
chr10_127508848_127510720 | 22.01 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr2_174347204_174348264 | 17.52 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr3_14886091_14887033 | 14.39 |
Car2 |
carbonic anhydrase 2 |
77 |
0.97 |
chr10_30763229_30763567 | 14.05 |
Gm48334 |
predicted gene, 48334 |
6177 |
0.15 |
chr13_91460972_91461704 | 13.43 |
Ssbp2 |
single-stranded DNA binding protein 2 |
157 |
0.97 |
chr2_153560652_153561518 | 12.53 |
Nol4l |
nucleolar protein 4-like |
31114 |
0.15 |
chr10_128804096_128805293 | 12.43 |
Tmem198b |
transmembrane protein 198b |
324 |
0.61 |
chr6_125095392_125097556 | 12.31 |
Chd4 |
chromodomain helicase DNA binding protein 4 |
95 |
0.84 |
chr9_75527103_75527470 | 11.88 |
Gm48789 |
predicted gene, 48789 |
6784 |
0.15 |
chr11_74575887_74576243 | 11.88 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
14059 |
0.18 |
chr12_103737920_103738559 | 11.88 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr17_79355135_79355983 | 11.85 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
468 |
0.67 |
chr11_105152665_105152916 | 11.71 |
Gm11620 |
predicted gene 11620 |
13830 |
0.13 |
chr12_103863072_103863984 | 11.65 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr11_102347634_102348245 | 11.65 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
12629 |
0.1 |
chr2_153492229_153493481 | 11.63 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr11_60114297_60115906 | 11.44 |
4930412M03Rik |
RIKEN cDNA 4930412M03 gene |
129 |
0.95 |
chr15_101976894_101977736 | 11.07 |
Krt78 |
keratin 78 |
23028 |
0.09 |
chr17_47535748_47536285 | 10.99 |
Ccnd3 |
cyclin D3 |
30775 |
0.1 |
chr4_126202831_126203382 | 10.67 |
Thrap3 |
thyroid hormone receptor associated protein 3 |
346 |
0.78 |
chr7_74182613_74183104 | 10.65 |
Gm27459 |
predicted gene, 27459 |
52700 |
0.15 |
chr3_65658208_65659857 | 10.37 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr5_96921082_96921373 | 10.04 |
Gm8013 |
predicted gene 8013 |
45 |
0.93 |
chr11_69837611_69838644 | 9.81 |
Nlgn2 |
neuroligin 2 |
343 |
0.43 |
chr14_69253618_69253952 | 9.75 |
Gm27222 |
predicted gene 27222 |
5361 |
0.11 |
chr4_106248411_106248570 | 9.68 |
Gm12724 |
predicted gene 12724 |
7274 |
0.16 |
chr11_3289074_3290615 | 9.63 |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
149 |
0.93 |
chr8_14888678_14889479 | 9.57 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
74 |
0.97 |
chr11_69854050_69854225 | 9.50 |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
1465 |
0.14 |
chr1_168287679_168288893 | 9.47 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr7_132776045_132776200 | 9.45 |
Fam53b |
family with sequence similarity 53, member B |
794 |
0.65 |
chr4_8689860_8690380 | 9.36 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr19_46849397_46849711 | 9.33 |
Cnnm2 |
cyclin M2 |
16106 |
0.17 |
chr9_21615608_21616677 | 9.31 |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
27 |
0.95 |
chr3_100488535_100489982 | 9.30 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr9_63550840_63550991 | 9.22 |
Gm16759 |
predicted gene, 16759 |
19563 |
0.18 |
chr3_90265231_90266258 | 9.20 |
Dennd4b |
DENN/MADD domain containing 4B |
559 |
0.53 |
chr14_76532822_76533109 | 9.13 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6349 |
0.21 |
chr11_102316544_102317735 | 9.10 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr11_115899580_115900578 | 9.04 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr1_128560554_128560734 | 9.01 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
31646 |
0.13 |
chr11_88068171_88069196 | 8.88 |
Vezf1 |
vascular endothelial zinc finger 1 |
404 |
0.76 |
chr2_154632522_154632679 | 8.80 |
Gm14198 |
predicted gene 14198 |
36 |
0.96 |
chr2_103888048_103888210 | 8.80 |
Gm13876 |
predicted gene 13876 |
195 |
0.9 |
chr2_180683538_180683827 | 8.79 |
Dido1 |
death inducer-obliterator 1 |
7727 |
0.12 |
chr17_34898151_34899707 | 8.74 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr8_23054484_23054794 | 8.64 |
Ank1 |
ankyrin 1, erythroid |
3620 |
0.21 |
chr5_96162084_96163134 | 8.63 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr17_49438920_49439085 | 8.61 |
Mocs1 |
molybdenum cofactor synthesis 1 |
5806 |
0.23 |
chr10_80016490_80016764 | 8.56 |
Arhgap45 |
Rho GTPase activating protein 45 |
26 |
0.94 |
chr15_83375189_83375572 | 8.55 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
8098 |
0.14 |
chr10_96616594_96617900 | 8.54 |
Btg1 |
BTG anti-proliferation factor 1 |
241 |
0.93 |
chr11_106612253_106612952 | 8.53 |
Tex2 |
testis expressed gene 2 |
328 |
0.89 |
chr11_57998862_57999212 | 8.50 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
10027 |
0.15 |
chr13_23697544_23698095 | 8.47 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr9_100643446_100643943 | 8.36 |
Stag1 |
stromal antigen 1 |
58 |
0.97 |
chr1_86479174_86479713 | 8.35 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr4_106582427_106583110 | 8.35 |
Gm12744 |
predicted gene 12744 |
6340 |
0.12 |
chr9_98299297_98299586 | 8.33 |
Gm28530 |
predicted gene 28530 |
2209 |
0.3 |
chr1_75218275_75219041 | 8.23 |
Tuba4a |
tubulin, alpha 4A |
34 |
0.92 |
chr8_23035278_23035450 | 8.19 |
Ank1 |
ankyrin 1, erythroid |
133 |
0.96 |
chr14_121131707_121131858 | 8.18 |
Farp1 |
FERM, RhoGEF (Arhgef) and pleckstrin domain protein 1 (chondrocyte-derived) |
29703 |
0.22 |
chr11_109517832_109518132 | 8.11 |
Gm22378 |
predicted gene, 22378 |
18158 |
0.13 |
chr4_137751327_137751655 | 8.05 |
Alpl |
alkaline phosphatase, liver/bone/kidney |
4344 |
0.21 |
chr10_128525093_128526268 | 8.01 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chr8_120372171_120372550 | 7.99 |
Gm22715 |
predicted gene, 22715 |
71189 |
0.09 |
chr7_29338853_29339176 | 7.90 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
49 |
0.96 |
chr9_64044981_64045602 | 7.90 |
Gm25606 |
predicted gene, 25606 |
3205 |
0.17 |
chr15_102017591_102018334 | 7.89 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr14_69523477_69523698 | 7.88 |
Gm27179 |
predicted gene 27179 |
11038 |
0.1 |
chr12_110974333_110974713 | 7.84 |
Ankrd9 |
ankyrin repeat domain 9 |
3732 |
0.14 |
chr5_33274034_33274924 | 7.79 |
Ctbp1 |
C-terminal binding protein 1 |
100 |
0.96 |
chr4_151957913_151958084 | 7.76 |
Dnajc11 |
DnaJ heat shock protein family (Hsp40) member C11 |
855 |
0.5 |
chr8_120536925_120537566 | 7.70 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
184 |
0.74 |
chr8_122537376_122538038 | 7.67 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
13622 |
0.09 |
chr6_86636441_86636743 | 7.66 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
8428 |
0.11 |
chr7_16046417_16047443 | 7.62 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr8_120368693_120369245 | 7.61 |
Gm22715 |
predicted gene, 22715 |
74580 |
0.08 |
chr7_135816621_135817118 | 7.57 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
36813 |
0.12 |
chr12_26469028_26470065 | 7.56 |
Cmpk2 |
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
342 |
0.84 |
chr7_141507249_141507413 | 7.54 |
Gm45416 |
predicted gene 45416 |
11272 |
0.08 |
chrX_20950586_20951120 | 7.53 |
Elk1 |
ELK1, member of ETS oncogene family |
245 |
0.87 |
chr6_127322417_127322756 | 7.53 |
Gm42458 |
predicted gene 42458 |
3271 |
0.16 |
chr8_4238228_4238907 | 7.52 |
Map2k7 |
mitogen-activated protein kinase kinase 7 |
173 |
0.62 |
chr4_151730005_151730352 | 7.49 |
Camta1 |
calmodulin binding transcription activator 1 |
131472 |
0.05 |
chrX_142680720_142682167 | 7.47 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr2_75659366_75659972 | 7.42 |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
351 |
0.52 |
chr6_4902832_4903901 | 7.41 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
7 |
0.97 |
chr4_53432052_53432206 | 7.41 |
Slc44a1 |
solute carrier family 44, member 1 |
8284 |
0.22 |
chr5_36724217_36724614 | 7.41 |
Gm43701 |
predicted gene 43701 |
24203 |
0.11 |
chr14_69305230_69305489 | 7.38 |
Synb |
syncytin b |
11060 |
0.09 |
chr15_103258381_103258750 | 7.32 |
Nfe2 |
nuclear factor, erythroid derived 2 |
162 |
0.91 |
chr8_23054025_23054342 | 7.31 |
Ank1 |
ankyrin 1, erythroid |
4076 |
0.2 |
chr8_84979246_84980613 | 7.29 |
Junb |
jun B proto-oncogene |
1211 |
0.19 |
chr8_105966447_105966892 | 7.25 |
Slc12a4 |
solute carrier family 12, member 4 |
572 |
0.48 |
chr13_45389281_45390472 | 7.21 |
Mylip |
myosin regulatory light chain interacting protein |
134 |
0.97 |
chr6_131387171_131387443 | 7.19 |
Ybx3 |
Y box protein 3 |
1131 |
0.41 |
chr4_86674298_86674491 | 7.15 |
Plin2 |
perilipin 2 |
4334 |
0.22 |
chr16_20703749_20704029 | 7.14 |
Clcn2 |
chloride channel, voltage-sensitive 2 |
4845 |
0.08 |
chr11_88999538_88999939 | 7.08 |
Trim25 |
tripartite motif-containing 25 |
362 |
0.77 |
chr7_98330060_98330318 | 7.08 |
Acer3 |
alkaline ceramidase 3 |
8981 |
0.18 |
chr11_77983926_77984968 | 7.05 |
Phf12 |
PHD finger protein 12 |
1645 |
0.25 |
chr7_25279370_25280622 | 7.04 |
Cic |
capicua transcriptional repressor |
355 |
0.74 |
chr12_24889410_24890042 | 7.03 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58095 |
0.09 |
chr9_61373312_61374646 | 7.02 |
Tle3 |
transducin-like enhancer of split 3 |
307 |
0.87 |
chr5_92127193_92127372 | 7.02 |
Gm24931 |
predicted gene, 24931 |
8999 |
0.12 |
chr15_96699649_96700462 | 7.02 |
Gm38144 |
predicted gene, 38144 |
118 |
0.76 |
chr9_57638713_57638942 | 7.02 |
Csk |
c-src tyrosine kinase |
4760 |
0.13 |
chr11_75927160_75927317 | 6.91 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
1347 |
0.46 |
chr5_137530580_137532081 | 6.88 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr11_49087898_49088318 | 6.88 |
Ifi47 |
interferon gamma inducible protein 47 |
156 |
0.73 |
chr12_105009915_105010683 | 6.86 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
490 |
0.67 |
chr5_8894851_8895125 | 6.86 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
1039 |
0.47 |
chr10_80150235_80151164 | 6.84 |
Midn |
midnolin |
242 |
0.82 |
chr2_75703696_75705127 | 6.81 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr11_102145362_102145760 | 6.79 |
Nags |
N-acetylglutamate synthase |
12 |
0.91 |
chr4_139179928_139180623 | 6.78 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr7_141558984_141559277 | 6.78 |
Ap2a2 |
adaptor-related protein complex 2, alpha 2 subunit |
3043 |
0.15 |
chr6_116351241_116351392 | 6.70 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
383 |
0.79 |
chr2_167628701_167629206 | 6.69 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
3014 |
0.15 |
chr9_123958262_123958421 | 6.69 |
Ccr1 |
chemokine (C-C motif) receptor 1 |
10351 |
0.17 |
chr19_5665499_5665819 | 6.67 |
Pcnx3 |
pecanex homolog 3 |
539 |
0.5 |
chr6_120579566_120580923 | 6.66 |
Gm44124 |
predicted gene, 44124 |
68 |
0.96 |
chr18_67436617_67436802 | 6.66 |
Afg3l2 |
AFG3-like AAA ATPase 2 |
761 |
0.59 |
chr3_51340298_51341882 | 6.63 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr12_111443905_111444085 | 6.62 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
329 |
0.82 |
chr2_155989219_155989379 | 6.62 |
Cep250 |
centrosomal protein 250 |
3384 |
0.13 |
chr7_140115577_140116584 | 6.57 |
Paox |
polyamine oxidase (exo-N4-amino) |
258 |
0.51 |
chr13_9426283_9426644 | 6.56 |
Gm48889 |
predicted gene, 48889 |
13946 |
0.16 |
chr16_4559726_4560765 | 6.56 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr6_83395962_83396123 | 6.55 |
Mir6374 |
microRNA 6374 |
5060 |
0.13 |
chr10_62326873_62327250 | 6.55 |
Hk1 |
hexokinase 1 |
706 |
0.65 |
chr13_92592779_92592980 | 6.52 |
Spz1 |
spermatogenic leucine zipper 1 |
16707 |
0.18 |
chr11_116616197_116616677 | 6.51 |
Rhbdf2 |
rhomboid 5 homolog 2 |
7763 |
0.1 |
chr4_150871347_150872456 | 6.51 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
16828 |
0.12 |
chr4_134865487_134865649 | 6.47 |
Rhd |
Rh blood group, D antigen |
1032 |
0.5 |
chr3_102144465_102144767 | 6.47 |
Casq2 |
calsequestrin 2 |
565 |
0.68 |
chr6_116350734_116350997 | 6.46 |
Marchf8 |
membrane associated ring-CH-type finger 8 |
27 |
0.96 |
chr13_44733414_44734122 | 6.44 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
272 |
0.94 |
chr16_23294359_23294543 | 6.40 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
3981 |
0.21 |
chr2_30417882_30418061 | 6.38 |
Ptpa |
protein phosphatase 2 protein activator |
1669 |
0.2 |
chr12_76709620_76710348 | 6.37 |
Sptb |
spectrin beta, erythrocytic |
39 |
0.98 |
chr3_121291927_121292619 | 6.34 |
Alg14 |
asparagine-linked glycosylation 14 |
383 |
0.82 |
chr4_86634480_86634666 | 6.34 |
Gm12551 |
predicted gene 12551 |
3322 |
0.19 |
chr11_102218354_102219649 | 6.31 |
Hdac5 |
histone deacetylase 5 |
72 |
0.94 |
chr8_126591174_126591799 | 6.31 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
2500 |
0.33 |
chr17_53566897_53568169 | 6.30 |
Kat2b |
K(lysine) acetyltransferase 2B |
562 |
0.71 |
chr8_83423048_83423368 | 6.25 |
Scoc |
short coiled-coil protein |
14619 |
0.13 |
chr3_89137003_89137461 | 6.24 |
Pklr |
pyruvate kinase liver and red blood cell |
609 |
0.47 |
chr5_117133502_117133674 | 6.23 |
Taok3 |
TAO kinase 3 |
0 |
0.97 |
chr15_81990604_81990888 | 6.22 |
Xrcc6 |
X-ray repair complementing defective repair in Chinese hamster cells 6 |
2911 |
0.11 |
chr10_75696702_75696890 | 6.21 |
Cabin1 |
calcineurin binding protein 1 |
3579 |
0.17 |
chr1_173333973_173334136 | 6.21 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
304 |
0.86 |
chr11_69919627_69920112 | 6.20 |
Eif5a |
eukaryotic translation initiation factor 5A |
761 |
0.32 |
chr9_21091378_21091846 | 6.19 |
1700084C06Rik |
RIKEN cDNA 1700084C06 gene |
143 |
0.62 |
chr1_133825622_133825990 | 6.18 |
Gm10537 |
predicted gene 10537 |
3722 |
0.17 |
chr19_5726991_5727271 | 6.18 |
Gm16538 |
predicted gene 16538 |
75 |
0.87 |
chr2_158141595_158141856 | 6.15 |
Tgm2 |
transglutaminase 2, C polypeptide |
1989 |
0.27 |
chr1_181256233_181256640 | 6.15 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
14116 |
0.14 |
chr13_54680594_54680864 | 6.13 |
Rnf44 |
ring finger protein 44 |
3343 |
0.17 |
chr11_107397698_107397986 | 6.13 |
Gm11712 |
predicted gene 11712 |
10859 |
0.13 |
chr7_80186556_80187259 | 6.09 |
Sema4b |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
29 |
0.96 |
chr10_94047858_94048136 | 6.07 |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
11996 |
0.12 |
chr7_144747827_144748160 | 6.06 |
Gm44930 |
predicted gene 44930 |
801 |
0.5 |
chr11_95040343_95041272 | 6.05 |
Pdk2 |
pyruvate dehydrogenase kinase, isoenzyme 2 |
68 |
0.95 |
chr7_143006404_143006665 | 6.05 |
Tspan32 |
tetraspanin 32 |
606 |
0.58 |
chr8_23031479_23031736 | 6.02 |
Ank1 |
ankyrin 1, erythroid |
3492 |
0.23 |
chr3_142744544_142744893 | 5.98 |
Gm15540 |
predicted gene 15540 |
37 |
0.96 |
chr9_35105556_35106095 | 5.96 |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
842 |
0.54 |
chr19_53313026_53314073 | 5.96 |
Mxi1 |
MAX interactor 1, dimerization protein |
483 |
0.75 |
chr17_84153970_84154239 | 5.92 |
Gm19696 |
predicted gene, 19696 |
2322 |
0.26 |
chr18_61952693_61953227 | 5.92 |
Sh3tc2 |
SH3 domain and tetratricopeptide repeats 2 |
115 |
0.97 |
chr15_67121102_67121454 | 5.91 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
7286 |
0.27 |
chr7_28179836_28180482 | 5.87 |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
107 |
0.93 |
chr14_70074487_70075571 | 5.87 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr15_9070501_9072193 | 5.86 |
Nadk2 |
NAD kinase 2, mitochondrial |
87 |
0.98 |
chr4_33923766_33925291 | 5.85 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr5_146308140_146308320 | 5.83 |
Cdk8 |
cyclin-dependent kinase 8 |
11865 |
0.17 |
chr1_180903101_180903294 | 5.80 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
1096 |
0.32 |
chr12_103388821_103389428 | 5.79 |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
139 |
0.92 |
chr7_24373511_24373960 | 5.78 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
3397 |
0.11 |
chr3_122111807_122112155 | 5.77 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
8059 |
0.18 |
chr13_107100581_107100778 | 5.76 |
Gm31452 |
predicted gene, 31452 |
36984 |
0.15 |
chr11_85799610_85799788 | 5.75 |
Bcas3 |
breast carcinoma amplified sequence 3 |
2122 |
0.21 |
chr2_29035787_29036046 | 5.75 |
Cfap77 |
cilia and flagella associated protein 77 |
3444 |
0.21 |
chr17_25943201_25943527 | 5.75 |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
502 |
0.51 |
chr17_24208511_24209934 | 5.75 |
Ntn3 |
netrin 3 |
177 |
0.67 |
chr2_158305932_158306715 | 5.74 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chr7_16310401_16311417 | 5.74 |
Bbc3 |
BCL2 binding component 3 |
454 |
0.72 |
chr7_115845502_115845659 | 5.74 |
Sox6 |
SRY (sex determining region Y)-box 6 |
525 |
0.87 |
chr19_10634117_10635337 | 5.74 |
Vwce |
von Willebrand factor C and EGF domains |
445 |
0.68 |
chr8_83662115_83663206 | 5.73 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
4018 |
0.12 |
chr5_115266451_115266643 | 5.72 |
Gm13831 |
predicted gene 13831 |
3454 |
0.1 |
chr5_149635760_149636523 | 5.72 |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
30 |
0.97 |
chr11_31896789_31896941 | 5.71 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
23590 |
0.18 |
chr9_57261867_57262443 | 5.70 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
392 |
0.83 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.1 | 15.4 | GO:0042938 | dipeptide transport(GO:0042938) |
4.5 | 18.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
4.1 | 12.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
4.1 | 4.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
4.0 | 12.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
4.0 | 11.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.9 | 11.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
3.8 | 15.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
3.8 | 11.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
3.8 | 11.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.8 | 18.8 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
3.6 | 10.7 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
3.4 | 10.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
3.4 | 3.4 | GO:0030575 | nuclear body organization(GO:0030575) |
3.4 | 13.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
3.4 | 3.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
3.3 | 6.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
3.3 | 3.3 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
3.3 | 13.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.2 | 3.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.2 | 3.2 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
3.1 | 15.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.0 | 9.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
3.0 | 18.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
3.0 | 8.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
3.0 | 14.8 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.9 | 8.6 | GO:0071314 | cellular response to cocaine(GO:0071314) |
2.8 | 5.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.8 | 8.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.7 | 8.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.7 | 8.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.7 | 5.4 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
2.7 | 8.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.7 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.6 | 7.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.6 | 7.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.6 | 7.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
2.6 | 10.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
2.6 | 7.7 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.6 | 10.2 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.6 | 2.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.5 | 15.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.5 | 7.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
2.4 | 9.7 | GO:0007296 | vitellogenesis(GO:0007296) |
2.4 | 9.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.4 | 7.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.3 | 21.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.3 | 9.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.3 | 9.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.3 | 23.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.3 | 6.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.3 | 6.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.3 | 11.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.3 | 9.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.2 | 6.7 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
2.2 | 53.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.2 | 6.7 | GO:0050904 | diapedesis(GO:0050904) |
2.2 | 8.9 | GO:0061724 | lipophagy(GO:0061724) |
2.2 | 11.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.2 | 17.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.2 | 2.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
2.2 | 4.4 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
2.2 | 6.6 | GO:0008050 | female courtship behavior(GO:0008050) |
2.2 | 10.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.2 | 10.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.2 | 15.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
2.2 | 8.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.1 | 2.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.1 | 8.5 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
2.1 | 6.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.1 | 6.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.1 | 2.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.1 | 2.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
2.1 | 6.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 6.2 | GO:0040031 | snRNA modification(GO:0040031) |
2.0 | 10.2 | GO:0072553 | terminal button organization(GO:0072553) |
2.0 | 6.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.0 | 6.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
2.0 | 10.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.0 | 10.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.0 | 6.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
2.0 | 10.0 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.9 | 5.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.9 | 7.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.9 | 9.5 | GO:0097459 | iron ion import into cell(GO:0097459) |
1.9 | 7.6 | GO:0008228 | opsonization(GO:0008228) |
1.9 | 5.7 | GO:0061010 | gall bladder development(GO:0061010) |
1.9 | 7.4 | GO:0080009 | mRNA methylation(GO:0080009) |
1.9 | 3.7 | GO:0003032 | detection of oxygen(GO:0003032) |
1.9 | 5.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.8 | 9.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.8 | 18.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.8 | 12.7 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.8 | 7.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.8 | 16.0 | GO:0046697 | decidualization(GO:0046697) |
1.8 | 1.8 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.8 | 26.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.8 | 7.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.7 | 7.0 | GO:0009597 | detection of virus(GO:0009597) |
1.7 | 7.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.7 | 6.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.7 | 3.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 5.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.7 | 10.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.7 | 6.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.7 | 1.7 | GO:0051304 | chromosome separation(GO:0051304) |
1.7 | 5.1 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.7 | 8.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.7 | 10.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.7 | 8.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.7 | 6.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.6 | 4.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.6 | 8.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.6 | 3.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
1.6 | 6.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.6 | 6.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.6 | 9.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
1.6 | 3.3 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.6 | 4.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.6 | 3.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.6 | 6.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.6 | 4.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.6 | 8.0 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.6 | 1.6 | GO:0007127 | meiosis I(GO:0007127) |
1.6 | 6.4 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.6 | 1.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.6 | 14.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.6 | 7.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.6 | 9.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.6 | 17.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.6 | 1.6 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.6 | 4.7 | GO:0032264 | IMP salvage(GO:0032264) |
1.5 | 3.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 7.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.5 | 3.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.5 | 4.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.5 | 4.6 | GO:0000087 | mitotic M phase(GO:0000087) |
1.5 | 6.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
1.5 | 3.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.5 | 4.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.5 | 7.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.5 | 4.5 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.5 | 3.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
1.5 | 3.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.5 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.5 | 6.0 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.5 | 7.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.5 | 1.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.5 | 10.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.5 | 4.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.5 | 7.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.5 | 4.4 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
1.5 | 4.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.5 | 5.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.5 | 7.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.5 | 1.5 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.5 | 5.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.4 | 4.3 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 1.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.4 | 1.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.4 | 7.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.4 | 4.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.4 | 5.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.4 | 2.9 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.4 | 2.9 | GO:0015793 | glycerol transport(GO:0015793) |
1.4 | 5.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
1.4 | 2.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.4 | 5.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.4 | 7.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.4 | 4.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.4 | 4.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.4 | 4.2 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
1.4 | 7.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.4 | 1.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.4 | 2.8 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.4 | 2.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.4 | 6.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.4 | 4.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.4 | 1.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.4 | 4.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.4 | 9.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.4 | 4.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.4 | 4.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.4 | 6.8 | GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
1.4 | 5.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 4.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
1.3 | 4.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.3 | 1.3 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.3 | 4.0 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.3 | 4.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.3 | 14.6 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.3 | 4.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.3 | 4.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.3 | 6.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.3 | 10.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.3 | 9.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.3 | 4.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 14.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.3 | 1.3 | GO:0019086 | late viral transcription(GO:0019086) |
1.3 | 11.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.3 | 2.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.3 | 5.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.3 | 3.9 | GO:0061511 | centriole elongation(GO:0061511) |
1.3 | 1.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.3 | 5.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.3 | 11.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.3 | 6.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.3 | 1.3 | GO:0036503 | ERAD pathway(GO:0036503) |
1.3 | 2.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 8.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.3 | 8.8 | GO:0032782 | bile acid secretion(GO:0032782) |
1.3 | 3.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.3 | 6.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.3 | 12.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
1.3 | 13.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.3 | 5.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.3 | 1.3 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
1.3 | 6.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.2 | 2.5 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.2 | 1.2 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.2 | 2.5 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.2 | 3.7 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.2 | 4.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.2 | 6.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.2 | 6.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.2 | 7.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.2 | 8.6 | GO:0010226 | response to lithium ion(GO:0010226) |
1.2 | 3.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.2 | 4.9 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.2 | 6.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.2 | 6.1 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.2 | 3.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 6.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 4.8 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.2 | 7.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.2 | 2.4 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.2 | 6.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.2 | 6.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.2 | 9.6 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.2 | 2.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 4.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.2 | 3.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.2 | 2.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.2 | 3.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.2 | 3.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.2 | 7.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.2 | 2.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.2 | 3.5 | GO:0072718 | response to cisplatin(GO:0072718) |
1.2 | 3.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.2 | 8.2 | GO:0034063 | stress granule assembly(GO:0034063) |
1.2 | 3.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.2 | 1.2 | GO:0039534 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 2.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.2 | 2.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
1.2 | 7.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.2 | 3.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.2 | 1.2 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.2 | 3.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.2 | 5.8 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.2 | 4.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.2 | 6.9 | GO:0015871 | choline transport(GO:0015871) |
1.2 | 3.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.1 | 3.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.1 | 4.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.1 | 4.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.1 | 6.9 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 1.1 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.1 | 3.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 2.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.1 | 5.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.1 | 7.9 | GO:0051383 | kinetochore organization(GO:0051383) |
1.1 | 3.4 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
1.1 | 15.7 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
1.1 | 4.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.1 | 2.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 4.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.1 | 3.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.1 | 8.9 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.1 | 2.2 | GO:0035425 | autocrine signaling(GO:0035425) |
1.1 | 1.1 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
1.1 | 5.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
1.1 | 3.3 | GO:0015705 | iodide transport(GO:0015705) |
1.1 | 6.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.1 | 4.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.1 | 4.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.1 | 8.7 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
1.1 | 2.2 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.1 | 4.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.1 | 2.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
1.1 | 2.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
1.1 | 3.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.1 | 11.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 3.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.1 | 1.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
1.1 | 3.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.1 | 1.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.1 | 2.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.1 | 4.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.1 | 1.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 1.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.1 | 2.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.1 | 3.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.1 | 4.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.1 | 3.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 2.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.1 | 10.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.1 | 3.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.1 | 7.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 3.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.0 | 3.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.0 | 1.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.0 | 3.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 4.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.0 | 1.0 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.0 | 3.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
1.0 | 12.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.0 | 3.1 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 9.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.0 | 2.1 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.0 | 3.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.0 | 4.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.0 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.0 | 7.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 2.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 12.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
1.0 | 2.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.0 | 4.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.0 | 13.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.0 | 2.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.0 | 2.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.0 | 5.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 5.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.0 | 1.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.0 | 4.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 4.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
1.0 | 2.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.0 | 2.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 3.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.0 | 3.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 1.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.0 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 2.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.0 | 2.9 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.0 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 3.9 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.0 | 17.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 2.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.0 | 2.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.0 | 2.9 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
1.0 | 7.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.0 | 26.2 | GO:0006953 | acute-phase response(GO:0006953) |
1.0 | 2.9 | GO:0042023 | DNA endoreduplication(GO:0042023) |
1.0 | 2.9 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.0 | 1.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.0 | 3.8 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.0 | 1.0 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.0 | 2.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.0 | 5.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.0 | 5.7 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.9 | 1.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.9 | 7.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.9 | 8.5 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.9 | 1.9 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.9 | 1.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 2.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.9 | 0.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.9 | 0.9 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.9 | 8.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.9 | 3.7 | GO:0072611 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.9 | 2.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 8.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.9 | 2.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.9 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.9 | 3.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.9 | 1.8 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.9 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.9 | 3.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.9 | 0.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.9 | 5.5 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.9 | 9.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.9 | 10.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.9 | 5.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 3.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.9 | 3.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 5.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.9 | 4.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.9 | 1.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 3.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.9 | 2.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 0.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.9 | 1.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.9 | 4.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.9 | 0.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.9 | 0.9 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.9 | 1.8 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.9 | 2.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.9 | 5.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.9 | 29.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.9 | 8.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.9 | 1.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.9 | 0.9 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.9 | 5.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.9 | 0.9 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.9 | 10.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.9 | 10.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 2.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.9 | 1.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 1.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.9 | 3.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.9 | 7.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 0.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.9 | 3.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 3.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.9 | 1.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 1.7 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.9 | 2.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.9 | 5.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.9 | 5.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.9 | 5.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.9 | 5.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.9 | 3.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.9 | 1.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.9 | 2.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.9 | 1.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.9 | 2.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.8 | 5.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.8 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.8 | 4.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 6.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.8 | 1.7 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.8 | 1.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.8 | 4.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 4.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.8 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 5.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.8 | 3.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.8 | 2.5 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.8 | 4.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.8 | 15.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.8 | 2.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 5.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.8 | 5.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.8 | 5.8 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.8 | 2.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.8 | 8.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.8 | 2.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.8 | 3.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 3.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.8 | 3.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.8 | 5.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 4.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.8 | 2.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 4.8 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.8 | 5.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.8 | 2.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.8 | 3.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.8 | 2.4 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.8 | 2.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.8 | 8.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.8 | 0.8 | GO:0015791 | polyol transport(GO:0015791) |
0.8 | 4.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 7.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.8 | 4.8 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 1.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 0.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.8 | 7.9 | GO:0032392 | DNA geometric change(GO:0032392) |
0.8 | 3.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 3.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.8 | 1.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.8 | 4.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.8 | 0.8 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.8 | 11.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.8 | 1.6 | GO:0019081 | viral translation(GO:0019081) viral translational termination-reinitiation(GO:0075525) |
0.8 | 3.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.8 | 2.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.8 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 3.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.8 | 3.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.8 | 0.8 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.8 | 0.8 | GO:0034204 | lipid translocation(GO:0034204) |
0.8 | 3.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.8 | 2.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.8 | 0.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.8 | 12.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.8 | 4.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.8 | 7.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.8 | 3.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.8 | 4.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.8 | 2.3 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.8 | 2.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 3.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.8 | 2.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.8 | 9.8 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.8 | 4.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.8 | 0.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.7 | 1.5 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 2.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.7 | 11.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.7 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 3.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.7 | 2.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.7 | 1.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 0.7 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.7 | 3.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.7 | 14.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.7 | 2.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 2.2 | GO:0000237 | leptotene(GO:0000237) |
0.7 | 1.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.7 | 15.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.7 | 3.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.7 | 1.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.7 | 0.7 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.7 | 2.2 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 0.7 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.7 | 6.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.7 | 2.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 2.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.7 | 10.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.7 | 1.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.7 | 11.7 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 3.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 5.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 0.7 | GO:0034728 | nucleosome organization(GO:0034728) |
0.7 | 1.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.7 | 8.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.7 | 0.7 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.7 | 9.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 2.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.7 | 2.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.7 | 3.6 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.7 | 11.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.7 | 1.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.7 | 2.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 1.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 1.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 3.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.7 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 2.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 2.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 7.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.7 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.7 | 1.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 28.9 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.7 | 7.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.7 | 4.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.7 | 2.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 2.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.7 | 8.4 | GO:0006301 | postreplication repair(GO:0006301) |
0.7 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 2.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 4.2 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.7 | 2.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 3.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 4.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 2.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.7 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.7 | 1.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.7 | 4.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.7 | 2.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.7 | 0.7 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.7 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 2.7 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.7 | 1.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 1.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.7 | 8.8 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 1.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.7 | 4.1 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.7 | 3.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.7 | 2.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.7 | 2.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 2.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.7 | 1.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.7 | 2.7 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.7 | 5.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.7 | 0.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.7 | 5.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.7 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.7 | 2.0 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.7 | 4.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 2.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.7 | 0.7 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.7 | 7.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.7 | 3.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.7 | 3.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.7 | 2.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.7 | 2.0 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.7 | 1.3 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.7 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 3.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.7 | 4.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.7 | 0.7 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.6 | 3.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.6 | 1.9 | GO:0009838 | abscission(GO:0009838) |
0.6 | 1.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 8.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.6 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.6 | 3.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 2.6 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.6 | 2.6 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.6 | 0.6 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.6 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 2.6 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.6 | 5.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 1.9 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.6 | 2.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.6 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.6 | 1.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 1.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 11.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 1.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 1.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.6 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.6 | 3.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.6 | 2.5 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 1.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.6 | 2.5 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 0.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.6 | 2.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.6 | 2.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.6 | 7.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 1.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.6 | 2.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 1.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 0.6 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.6 | 1.8 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.6 | 6.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.6 | 2.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 1.2 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.6 | 1.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 1.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.6 | 6.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.6 | 2.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 6.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.6 | 4.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.6 | 1.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 4.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.6 | 6.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 1.2 | GO:0051231 | spindle elongation(GO:0051231) |
0.6 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.6 | 3.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.6 | 2.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 5.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 1.8 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.6 | 0.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.6 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 1.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 1.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.6 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 2.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 0.6 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.6 | 1.8 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 1.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.6 | 1.2 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.6 | 0.6 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.6 | 11.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.6 | 4.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.6 | 1.2 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.6 | 0.6 | GO:0016233 | telomere capping(GO:0016233) |
0.6 | 1.2 | GO:0070268 | cornification(GO:0070268) |
0.6 | 4.0 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.6 | 2.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.6 | 4.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.6 | 0.6 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.6 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.6 | 1.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.6 | 1.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 6.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 0.6 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.6 | 1.7 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.6 | 1.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.6 | 6.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.6 | 1.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.6 | 8.4 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.6 | 0.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.6 | 8.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.6 | 12.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.6 | 2.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.6 | 8.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.6 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 4.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 2.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 6.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.5 | 1.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.5 | 1.1 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.5 | 5.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.5 | 1.6 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 0.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.5 | 1.1 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.5 | 9.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 3.8 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.5 | 1.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.5 | 2.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 0.5 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.5 | 2.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 1.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.5 | 0.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.5 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.5 | 1.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 4.8 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.5 | 10.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.5 | 0.5 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.5 | 1.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.5 | 8.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 3.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 4.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 2.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.5 | 1.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.5 | 1.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 4.2 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.5 | 2.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 0.5 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 1.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 1.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 5.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.5 | 4.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.5 | 4.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.5 | 8.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.5 | 4.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 1.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 0.5 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.5 | 2.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.5 | 2.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.5 | 3.6 | GO:0030220 | platelet formation(GO:0030220) |
0.5 | 0.5 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 7.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.5 | 7.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.5 | 17.6 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.5 | 4.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.5 | 1.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 2.1 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 2.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 2.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 1.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 2.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.5 | 2.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.5 | 0.5 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.5 | 3.6 | GO:1902230 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 2.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 2.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.5 | 0.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 2.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.5 | 2.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.5 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 4.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.5 | 1.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.5 | 2.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 0.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.5 | 0.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 6.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.5 | 0.5 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 12.3 | GO:0016575 | histone deacetylation(GO:0016575) |
0.5 | 1.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 1.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 2.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 2.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 0.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 0.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 4.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 1.0 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) positive regulation of histone phosphorylation(GO:0033129) |
0.5 | 1.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 7.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.5 | 1.4 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 1.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 3.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 2.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.5 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.5 | 1.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 0.5 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.5 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 1.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 26.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.5 | 2.8 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.5 | 0.9 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.5 | 2.8 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 4.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 3.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 1.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 1.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.5 | 0.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.5 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.5 | 1.4 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.5 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 1.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 | 2.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.5 | 0.5 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.5 | 2.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.5 | 8.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.4 | 2.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 1.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 0.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 1.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.4 | 1.8 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 2.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 2.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 4.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.4 | 4.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.4 | 0.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.4 | 2.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.4 | 2.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 5.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 4.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.4 | 0.4 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
0.4 | 3.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.9 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 1.3 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.4 | 2.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.4 | 9.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.4 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.4 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 12.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.4 | 3.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.4 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.4 | 2.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 1.7 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 9.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.4 | 14.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 0.4 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.4 | 0.4 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 3.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 7.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 0.8 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 1.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.4 | 2.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 2.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 1.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.4 | 5.4 | GO:0032648 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.4 | 0.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 2.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.6 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 3.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 10.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 3.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.4 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 0.8 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.4 | 0.8 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.4 | 3.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 2.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.4 | 3.6 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 8.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 3.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.4 | 9.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 12.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 0.4 | GO:0036394 | amylase secretion(GO:0036394) |
0.4 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.4 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 2.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 10.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 0.4 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 2.7 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.4 | 1.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 0.4 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.4 | 2.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 0.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.4 | 1.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.4 | 1.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 4.7 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.4 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.4 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 1.2 | GO:0007567 | parturition(GO:0007567) |
0.4 | 5.0 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.4 | 1.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 3.4 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.4 | 1.5 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.4 | 2.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 5.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 1.9 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.4 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 1.1 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.4 | 6.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.4 | 4.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.4 | 1.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 14.8 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 8.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 0.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.4 | 0.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 0.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 3.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 0.7 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.4 | 13.6 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.4 | 1.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.7 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 3.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 3.5 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 0.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.4 | 0.7 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.4 | 12.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.4 | 1.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 0.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.4 | 1.8 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.4 | 1.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 0.4 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 0.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.3 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 0.7 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.3 | 1.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 1.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.3 | 1.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 3.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.3 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 4.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 1.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 2.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 1.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 3.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.3 | 1.0 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.3 | 2.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 3.0 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.3 | 2.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.3 | 0.7 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 0.7 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.3 | 8.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 1.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 1.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 0.6 | GO:0006833 | water transport(GO:0006833) |
0.3 | 2.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 2.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 1.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 2.8 | GO:0098534 | centriole assembly(GO:0098534) |
0.3 | 0.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 1.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 0.3 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.3 | 0.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.3 | 1.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.3 | 0.3 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.3 | 0.3 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 2.4 | GO:0032438 | melanosome organization(GO:0032438) |
0.3 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 1.5 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 3.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 5.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.3 | 1.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.3 | 0.3 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.3 | 5.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 0.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 3.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.3 | 2.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.3 | 1.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.6 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 3.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 5.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 3.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.3 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.5 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.3 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 0.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 0.6 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.9 | GO:1904358 | positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.3 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 2.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.3 | GO:0072007 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.3 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 1.4 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.3 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 9.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.3 | 1.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 1.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.3 | 1.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.3 | 14.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 0.3 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 1.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 1.7 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.3 | 0.3 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 1.4 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.3 | 0.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 0.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 0.3 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.3 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 5.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 1.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 0.5 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.3 | 1.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.3 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.5 | GO:0098754 | detoxification(GO:0098754) |
0.3 | 0.5 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.3 | 2.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 3.7 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.3 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 1.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.3 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 0.5 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 0.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 0.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.3 | 1.6 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 0.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.3 | 0.3 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 1.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 0.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.3 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 0.8 | GO:0015669 | gas transport(GO:0015669) |
0.3 | 1.8 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.3 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 1.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.3 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.3 | 2.0 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 1.0 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 3.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.5 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 1.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 4.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 1.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 1.7 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 1.2 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 1.2 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 1.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 5.3 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 | 0.2 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 1.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 3.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 6.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 2.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 2.1 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 2.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 1.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 6.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 1.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 11.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 2.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.4 | GO:0001774 | microglial cell activation(GO:0001774) |
0.2 | 1.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.2 | 2.0 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.2 | 0.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.1 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 0.9 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 6.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.2 | 0.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 6.0 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 2.6 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 0.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 4.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.2 | 0.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 1.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 2.9 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.2 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.2 | GO:0009124 | nucleoside monophosphate biosynthetic process(GO:0009124) |
0.2 | 0.6 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.2 | 2.0 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.6 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 0.6 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 11.4 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 3.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 3.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 2.0 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 5.7 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.2 | 0.6 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 1.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.2 | 1.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 5.5 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.2 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 1.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 3.0 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 0.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.2 | 2.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 2.4 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.4 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.2 | 1.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 3.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.4 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 2.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 1.8 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.2 | 0.9 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 3.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 0.5 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.2 | 0.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.2 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.2 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.8 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.2 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 0.2 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.2 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 2.6 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.8 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.2 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 1.1 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 4.7 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 3.0 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.2 | 25.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.2 | 1.7 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.1 | 1.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 2.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.1 | 5.1 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 1.0 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 1.2 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.1 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 1.0 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.9 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 1.7 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 1.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 1.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 1.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.4 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.1 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 1.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 3.0 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.2 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.3 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 8.1 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 1.2 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 3.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.3 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 2.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
0.1 | 0.6 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.3 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.3 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 1.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.4 | GO:0061154 | morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.2 | GO:0000050 | urea cycle(GO:0000050) ornithine metabolic process(GO:0006591) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 2.1 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.2 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 1.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.1 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.1 | 0.1 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.4 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.1 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 1.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 1.6 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.1 | 0.1 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 11.6 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.1 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.1 | 0.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 1.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 2.3 | GO:0030217 | T cell differentiation(GO:0030217) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.4 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 1.0 | GO:0044839 | cell cycle G2/M phase transition(GO:0044839) |
0.1 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 2.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.2 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.0 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.0 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.0 | 2.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 3.8 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.0 | 0.1 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.3 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 3.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.2 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.1 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.0 | 2.1 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 28.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
3.5 | 14.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
3.5 | 10.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.2 | 9.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
3.1 | 12.5 | GO:0072487 | MSL complex(GO:0072487) |
2.7 | 8.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.5 | 19.9 | GO:0001650 | fibrillar center(GO:0001650) |
2.3 | 6.8 | GO:0097413 | Lewy body(GO:0097413) |
2.2 | 6.6 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.2 | 8.7 | GO:0005642 | annulate lamellae(GO:0005642) |
2.1 | 6.4 | GO:0005745 | m-AAA complex(GO:0005745) |
2.1 | 8.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
2.0 | 8.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.0 | 8.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
2.0 | 7.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.9 | 11.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.9 | 5.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.9 | 13.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.8 | 7.1 | GO:1990130 | Iml1 complex(GO:1990130) |
1.7 | 10.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.7 | 13.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.7 | 13.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.7 | 13.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.7 | 5.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.7 | 8.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.7 | 5.0 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.6 | 4.9 | GO:0016939 | kinesin II complex(GO:0016939) |
1.6 | 4.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.6 | 6.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.6 | 4.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.6 | 7.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.5 | 3.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.5 | 10.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.5 | 10.2 | GO:0042382 | paraspeckles(GO:0042382) |
1.4 | 15.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.4 | 21.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.4 | 13.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.4 | 12.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.4 | 20.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 10.9 | GO:0001939 | female pronucleus(GO:0001939) |
1.3 | 4.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.3 | 4.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.3 | 3.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.3 | 17.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.3 | 3.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.3 | 42.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.3 | 10.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.3 | 11.6 | GO:0016580 | Sin3 complex(GO:0016580) |
1.3 | 2.5 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.3 | 17.7 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 22.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
1.2 | 2.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.2 | 3.7 | GO:0031417 | NatC complex(GO:0031417) |
1.2 | 7.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.2 | 11.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.2 | 6.1 | GO:0030870 | Mre11 complex(GO:0030870) |
1.2 | 6.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 3.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.2 | 8.4 | GO:0031931 | TORC1 complex(GO:0031931) |
1.2 | 3.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 38.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 4.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.2 | 24.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.2 | 4.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.2 | 4.7 | GO:0042825 | TAP complex(GO:0042825) |
1.1 | 2.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.1 | 4.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.1 | 7.9 | GO:0033263 | CORVET complex(GO:0033263) |
1.1 | 5.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.1 | 14.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.1 | 8.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.1 | 7.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.1 | 3.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.1 | 3.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.1 | 3.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.0 | 4.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 3.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 5.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.0 | 11.2 | GO:0031143 | pseudopodium(GO:0031143) |
1.0 | 44.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.0 | 4.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.0 | 7.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 1.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.0 | 2.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 3.0 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 4.9 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 5.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.0 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.0 | 30.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 3.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 2.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.0 | 2.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.0 | 10.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.0 | 3.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.9 | 14.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 22.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.9 | 6.4 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 4.6 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 7.3 | GO:0043203 | axon hillock(GO:0043203) |
0.9 | 6.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.9 | 2.7 | GO:0036396 | MIS complex(GO:0036396) |
0.9 | 5.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.9 | 4.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.9 | 3.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.9 | 45.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.9 | 6.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 3.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 2.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.9 | 7.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.9 | 3.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.8 | 39.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.8 | 2.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 3.4 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 5.8 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 43.4 | GO:0016605 | PML body(GO:0016605) |
0.8 | 3.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.8 | 1.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.8 | 0.8 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 3.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 7.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.8 | 2.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 26.1 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.8 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.8 | 0.8 | GO:0042827 | platelet dense granule(GO:0042827) |
0.8 | 12.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.8 | 46.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.8 | 4.8 | GO:0031415 | NatA complex(GO:0031415) |
0.8 | 2.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 0.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.8 | 8.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 7.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 0.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.8 | 3.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 6.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 3.8 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 4.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 2.3 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 7.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 3.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.8 | 14.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.7 | 11.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.7 | 3.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.7 | 1.5 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 1.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.7 | 5.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 3.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.7 | 2.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.7 | 4.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 2.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.7 | 4.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 4.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.7 | 13.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 3.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 5.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.7 | 2.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 8.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.7 | 4.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.7 | 3.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.1 | GO:0043293 | apoptosome(GO:0043293) |
0.7 | 8.3 | GO:0036038 | MKS complex(GO:0036038) |
0.7 | 2.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 2.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 6.2 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.7 | 3.4 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 4.8 | GO:0002102 | podosome(GO:0002102) |
0.7 | 6.8 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 1.4 | GO:0055087 | Ski complex(GO:0055087) |
0.7 | 2.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.7 | 2.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 2.7 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 12.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 58.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 7.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.7 | 2.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 2.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 3.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.6 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 1.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 1.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 1.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 3.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.6 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 3.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.6 | 18.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 5.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 2.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 3.7 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.6 | 59.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.6 | 7.9 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 4.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 9.7 | GO:0043034 | costamere(GO:0043034) |
0.6 | 1.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.6 | 5.4 | GO:0042581 | specific granule(GO:0042581) |
0.6 | 1.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.6 | 10.7 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.6 | 4.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 4.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.6 | 4.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 2.9 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 8.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.6 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 6.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.6 | 6.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 7.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.6 | 17.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 11.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 28.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.6 | 3.9 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.6 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 1.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 4.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.5 | 3.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.5 | 1.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.5 | 2.2 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 4.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.5 | 2.7 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 8.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 3.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.5 | 6.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.5 | 2.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 10.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.5 | 1.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 4.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 10.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 4.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.5 | 3.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.5 | 9.8 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.5 | 2.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.5 | 4.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 7.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 2.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.5 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.5 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 2.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 2.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 15.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 1.5 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 11.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 14.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.5 | 13.7 | GO:0005776 | autophagosome(GO:0005776) |
0.5 | 21.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.5 | 7.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 2.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 2.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.5 | 5.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 4.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 1.9 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 5.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.5 | 2.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.5 | 20.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.5 | 1.4 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.5 | 22.6 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 17.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 2.3 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 5.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 0.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 3.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.5 | 24.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 16.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.5 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 8.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.4 | 1.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 2.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 4.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.4 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 4.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 2.6 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 2.6 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 5.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 11.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 6.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.4 | 19.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 37.9 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 1.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 16.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 8.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 0.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 13.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 25.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 3.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 15.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 417.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 1.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 0.8 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.4 | 3.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 0.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 93.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.4 | 5.3 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 4.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 5.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 37.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 6.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.3 | 1.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 2.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 1.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 18.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 13.4 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.6 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 57.4 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 2.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.3 | 82.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 0.9 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 6.1 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 5.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.3 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.3 | 199.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 15.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.3 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 2.8 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.2 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 17.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 7.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 45.2 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 106.7 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 31.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 1.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 13.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 2.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 2.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 4.6 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 55.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.4 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 2.9 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 29.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 32.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
4.0 | 4.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
3.5 | 14.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.5 | 7.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
3.5 | 10.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.4 | 10.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
3.4 | 23.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.1 | 24.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.1 | 12.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.0 | 9.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.8 | 16.7 | GO:0004064 | arylesterase activity(GO:0004064) |
2.7 | 8.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
2.6 | 7.9 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.6 | 10.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
2.5 | 10.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
2.5 | 7.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.5 | 10.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.3 | 21.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.3 | 9.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.3 | 9.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.3 | 9.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.2 | 4.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.2 | 6.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.2 | 6.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
2.2 | 13.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.2 | 28.0 | GO:0016208 | AMP binding(GO:0016208) |
2.1 | 8.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.1 | 8.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.1 | 6.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.1 | 8.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.0 | 6.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.0 | 8.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.0 | 9.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.0 | 5.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.9 | 11.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.9 | 3.9 | GO:0050692 | DBD domain binding(GO:0050692) |
1.9 | 5.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.9 | 1.9 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
1.9 | 5.6 | GO:0000339 | RNA cap binding(GO:0000339) |
1.9 | 5.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.8 | 5.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.8 | 5.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.8 | 5.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.8 | 5.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.8 | 7.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 7.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.7 | 10.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.7 | 7.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.7 | 24.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.7 | 1.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.7 | 10.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.7 | 6.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.7 | 5.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.7 | 9.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.6 | 3.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.6 | 4.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.6 | 6.4 | GO:0050693 | LBD domain binding(GO:0050693) |
1.6 | 3.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.6 | 4.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 12.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.5 | 1.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.5 | 4.5 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
1.5 | 1.5 | GO:0060229 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
1.5 | 6.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.5 | 43.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.5 | 9.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.5 | 10.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.5 | 11.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.5 | 4.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.5 | 5.9 | GO:0009374 | biotin binding(GO:0009374) |
1.5 | 4.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.5 | 7.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.4 | 4.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.4 | 4.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.4 | 7.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 4.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.4 | 4.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.4 | 23.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.4 | 5.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.4 | 4.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.4 | 5.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.4 | 4.2 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 5.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.4 | 5.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.4 | 15.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 6.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.3 | 25.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.3 | 55.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.3 | 4.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
1.3 | 11.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.3 | 2.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.3 | 6.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.3 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 3.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.3 | 3.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.3 | 6.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.3 | 3.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.3 | 5.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.3 | 1.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.3 | 7.7 | GO:0030274 | LIM domain binding(GO:0030274) |
1.3 | 3.8 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 28.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.3 | 11.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.3 | 10.2 | GO:0008430 | selenium binding(GO:0008430) |
1.3 | 3.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.3 | 6.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.3 | 10.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.3 | 6.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.3 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.2 | 3.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 3.7 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 2.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.2 | 6.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.2 | 20.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.2 | 3.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.2 | 12.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.2 | 3.6 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.2 | 3.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 3.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.2 | 4.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.2 | 3.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.2 | 1.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.2 | 3.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.2 | 7.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.2 | 4.7 | GO:0034618 | arginine binding(GO:0034618) |
1.2 | 15.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.2 | 3.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.2 | 3.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.1 | 4.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.1 | 5.6 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 19.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.1 | 3.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.1 | 3.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.1 | 3.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.1 | 3.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.1 | 12.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.1 | 3.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.1 | 7.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 4.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.1 | 8.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 3.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.1 | 28.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.1 | 1.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.1 | 5.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
1.1 | 2.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.1 | 7.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.1 | 8.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.1 | 2.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.0 | 9.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 9.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 5.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.0 | 4.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.0 | 2.1 | GO:0004359 | glutaminase activity(GO:0004359) |
1.0 | 4.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 8.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 44.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.0 | 4.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.0 | 9.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.0 | 20.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 5.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.0 | 4.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 7.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 2.0 | GO:0030911 | TPR domain binding(GO:0030911) |
1.0 | 8.9 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.0 | 2.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.0 | 4.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.0 | 2.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 2.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.0 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 3.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.0 | 28.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.0 | 3.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 3.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.0 | 3.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 9.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.0 | 3.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 5.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.9 | 3.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.9 | 8.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.9 | 15.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.9 | 2.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.9 | 13.0 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
0.9 | 1.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.9 | 3.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 5.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.9 | 6.4 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.9 | 14.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.9 | 1.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.9 | 9.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.9 | 8.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.9 | 2.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.9 | 18.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.9 | 12.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.9 | 53.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.9 | 15.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.9 | 1.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.9 | 3.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.9 | 2.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.9 | 5.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 7.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 5.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 4.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.9 | 7.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.9 | 2.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 0.9 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.9 | 2.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.8 | 7.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.8 | 3.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.8 | 13.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.8 | 3.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.8 | 8.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.8 | 7.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.8 | 0.8 | GO:0004096 | catalase activity(GO:0004096) |
0.8 | 2.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.8 | 1.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.8 | 13.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 2.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.8 | 4.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 3.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.8 | 0.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.8 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.8 | 4.9 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 8.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.8 | 0.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.8 | 1.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 3.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.8 | 4.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.8 | 4.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.8 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 0.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 2.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 3.2 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.8 | 2.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 3.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.8 | 1.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.8 | 6.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 1.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 2.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 4.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.8 | 2.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 4.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 3.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.8 | 2.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.8 | 7.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.8 | 13.6 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 1.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.8 | 4.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.7 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.7 | 2.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 9.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.7 | 1.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 5.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.7 | 2.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.7 | 4.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.7 | 5.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.7 | 1.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 3.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.7 | 2.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 5.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 2.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.7 | 6.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 3.6 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 3.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 6.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 2.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.7 | 4.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 7.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.7 | 5.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.7 | 5.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.7 | 2.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 3.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 4.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 8.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 9.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 2.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 2.1 | GO:0019002 | GMP binding(GO:0019002) |
0.7 | 8.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 7.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 2.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.7 | 7.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 2.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 5.4 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 2.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.7 | 17.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 18.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 4.7 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 6.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.7 | 2.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.7 | 3.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 4.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 4.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 2.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.7 | 2.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 7.8 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 4.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 2.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.6 | 4.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.6 | 3.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.6 | 9.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.6 | 1.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.6 | 19.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.6 | 4.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 17.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.6 | 3.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.6 | 4.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 6.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 5.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 1.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 3.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 3.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 0.6 | GO:0070492 | disaccharide binding(GO:0048030) oligosaccharide binding(GO:0070492) |
0.6 | 5.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 12.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 11.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.6 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 4.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.6 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 15.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 3.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.6 | 6.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 3.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 6.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 2.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 3.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 1.8 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 4.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 0.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.6 | 3.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 1.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.6 | 2.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.6 | 10.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.6 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 11.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 1.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.6 | 4.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 0.6 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.6 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 3.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.6 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 6.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.6 | 5.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 1.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.6 | 1.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 4.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 3.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.6 | 1.7 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 6.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 2.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.6 | 3.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.6 | 12.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.6 | 1.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 3.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 3.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.6 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.6 | 2.8 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.6 | 1.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 5.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 1.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.6 | 7.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.6 | 1.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 7.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.6 | 5.5 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.6 | 1.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 2.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.5 | 1.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 9.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.5 | 20.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.5 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 5.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 1.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 13.5 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 4.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 5.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 18.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.5 | 2.6 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 5.3 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.5 | 4.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 2.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 1.6 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.5 | 2.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 12.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 2.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 2.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 2.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 36.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 4.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.5 | 3.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 14.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.5 | 4.5 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 2.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 3.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 3.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 1.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 1.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 4.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 1.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 10.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 3.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 1.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.5 | 3.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 1.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 7.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 4.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 14.4 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.5 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 5.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 4.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.5 | 2.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 1.4 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.5 | 2.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 2.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 3.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 60.7 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 3.6 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 0.9 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 2.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 19.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 3.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 1.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 6.5 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.4 | 0.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 9.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 1.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 5.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 2.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 0.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.4 | 4.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 29.8 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 3.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 2.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.4 | 2.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 2.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.4 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 46.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 6.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 11.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 1.6 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 3.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 2.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 3.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 5.2 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) DNA-N1-methyladenine dioxygenase activity(GO:0043734) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.4 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.4 | 9.9 | GO:0019209 | kinase activator activity(GO:0019209) |
0.4 | 2.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 8.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.4 | 2.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 20.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 4.3 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.4 | 14.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 10.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 0.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 12.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 9.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.4 | 3.8 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 4.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.4 | 1.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 3.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.4 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 1.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 15.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 1.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 2.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 1.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.4 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.4 | 14.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 2.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 8.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 2.0 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.3 | 1.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 34.4 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.3 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 2.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 4.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 4.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 6.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 4.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 7.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.3 | 8.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 2.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 4.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 2.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 4.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 55.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.3 | 1.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 33.7 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.3 | 1.0 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 0.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 1.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 3.8 | GO:0015928 | fucosidase activity(GO:0015928) |
0.3 | 0.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 3.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 5.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 5.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 27.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.3 | 0.9 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 3.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 2.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 1.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 3.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 0.3 | GO:0015093 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 3.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 4.0 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 2.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 0.6 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 1.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 3.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 6.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 2.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 8.6 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 0.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 4.6 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 3.1 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.3 | 1.0 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.3 | 0.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 2.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 2.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 1.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 19.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 2.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 5.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 12.8 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 1.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 2.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 134.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 2.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 1.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 3.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 1.3 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.2 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
0.2 | 1.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 2.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 3.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 3.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 5.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 3.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 2.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 4.6 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 2.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.4 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 9.0 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 0.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.2 | 4.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.2 | 1.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 4.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 7.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 6.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 2.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.9 | GO:0016160 | amylase activity(GO:0016160) |
0.2 | 0.3 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 1.3 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.2 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 2.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 24.9 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 3.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.1 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 3.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 1.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 2.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 18.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.8 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 2.9 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 2.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 4.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 7.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 1.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 4.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 9.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 9.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 4.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.2 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 2.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
0.0 | 1.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 3.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.3 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 2.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 82.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.7 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.5 | 79.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.4 | 30.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.4 | 7.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.3 | 28.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.3 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.2 | 3.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.2 | 5.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.1 | 10.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 10.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.1 | 13.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.1 | 14.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.1 | 35.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.1 | 25.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 5.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 4.2 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 17.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.0 | 1.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.0 | 8.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.0 | 8.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 38.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.0 | 58.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.0 | 14.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 41.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.9 | 38.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.9 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.9 | 15.6 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 19.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 5.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 6.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 9.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.8 | 3.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.8 | 7.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 25.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 25.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 9.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 13.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 14.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 8.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 12.4 | PID ATM PATHWAY | ATM pathway |
0.6 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 15.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 7.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 1.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 2.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.6 | 7.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 6.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 4.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 3.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 14.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 12.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 20.4 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 2.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 11.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 15.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 10.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 8.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 5.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 3.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 7.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 0.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 12.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 12.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 5.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 6.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 16.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 3.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.4 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 4.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 14.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 4.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 6.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 5.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 1.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 2.7 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 5.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 4.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 7.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 5.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 6.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 1.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 4.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 4.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 6.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 5.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 4.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 3.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 2.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 9.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 3.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 1.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 17.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.9 | 5.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
1.9 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.8 | 11.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.8 | 21.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.7 | 10.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.6 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.6 | 14.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.6 | 16.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.6 | 27.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.5 | 25.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.5 | 16.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.4 | 15.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.4 | 12.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.4 | 46.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.4 | 15.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.4 | 1.4 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
1.4 | 33.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.3 | 21.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 16.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.3 | 20.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.2 | 26.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.2 | 4.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.2 | 14.7 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.2 | 17.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.2 | 17.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.2 | 2.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 12.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.1 | 18.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
1.1 | 18.8 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
1.1 | 6.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.1 | 6.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.1 | 15.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.1 | 13.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.1 | 9.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.1 | 4.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.1 | 19.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
1.1 | 18.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.1 | 1.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
1.0 | 10.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.0 | 6.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.0 | 10.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.0 | 19.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.0 | 27.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.0 | 2.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.0 | 11.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.0 | 3.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 15.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 16.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.0 | 19.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.0 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.0 | 13.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.0 | 1.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.9 | 9.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 22.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.9 | 7.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.9 | 11.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.9 | 4.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 4.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 8.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.9 | 9.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 12.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.9 | 3.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.9 | 8.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 17.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 14.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 12.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.9 | 9.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.8 | 12.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 9.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.8 | 1.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.8 | 8.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.8 | 25.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.8 | 0.8 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.8 | 55.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 4.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 7.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 12.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 19.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 5.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 5.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.8 | 8.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 14.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 6.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 24.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.7 | 13.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 3.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.7 | 10.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.7 | 3.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.7 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.7 | 1.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.7 | 10.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 12.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 6.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.7 | 19.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.7 | 18.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.7 | 0.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.7 | 25.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.7 | 9.9 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.7 | 5.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 17.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.6 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 3.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 52.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.6 | 1.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.6 | 5.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 10.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 4.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.6 | 1.8 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.6 | 12.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 30.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 4.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.6 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.6 | 24.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 15.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 48.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.6 | 12.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 15.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 2.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.6 | 2.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 5.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 6.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 0.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.5 | 17.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 13.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 6.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 7.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 15.7 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.5 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 12.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.5 | 5.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 5.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 1.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.5 | 22.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 1.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 7.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.5 | 5.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.5 | 8.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 12.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.5 | 7.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.5 | 5.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 7.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.4 | 2.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 5.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 1.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 2.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 3.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 4.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 1.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 8.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 3.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 1.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 6.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 3.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 9.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 5.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 21.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 1.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 7.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 3.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 9.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 0.3 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.3 | 2.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 9.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 9.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 5.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 6.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 1.2 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.3 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 2.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 3.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 1.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 21.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 27.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 7.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 5.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.2 | 6.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.2 | 2.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.7 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.2 | 3.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 3.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.2 | 3.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 7.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 5.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 1.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 4.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 3.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.3 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 2.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 2.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.0 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |